About Trimax Bio sciences
Trimax Bio sciences is a Healthcare company based in Raichur (India) founded in 2011 by K Jagadeeswari and Nageswara Rao, and was acquired by Sigachi in August 2023. Non-infringing pharmaceutical research and healthcare products are developed. Trimax Bio sciences has raised $590.9 thousand across 2 funding rounds from investors including Sigachi, Srinivasulu Devabattini and Nimmagadda Venkateswarlu. The company has 113 employees. Trimax Bio sciences was last valued at $9.23 million in January 2019. Its Indian entity Trimax Bio Sciences Private Limited reported revenue of ₹29.26 Cr. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
Trimax Bio sciences was established in 2011 in Raichur, India, within the pharmaceutical sector. Research on non-infringing processes is conducted, alongside manufacturing of various healthcare intermediates. Products such as metformin, pregabalin, dimethylphenoxyacetic acid, and pantoprazole sodium sesquihydrate are produced to support broader pharmaceutical applications. Operations remain centered on these core activities in the Indian market.
- Headquarters Raichur, India
- Employees 113
- Founders K Jagadeeswari, Nageswara Rao
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website trimaxbiosciences.com
- Acquired by Sigachi (Aug 2023)
- Legal Name Trimax Bio Sciences Private Limited
- Date of Incorporation 11 May, 2010
- Jurisdiction Hyderabad, Telangana, India
Associated legal entities of Trimax Bio sciences
Trimax Bio sciences operates through Trimax Bio Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Trimax Bio Sciences Private Limited CIN U24297TG2010PTC068376 | Active | 11 May 2010 | Hyderabad, Telangana | ₹29.3 Cr | 113 | 7 | View details |
Funding Insights of Trimax Bio sciences
Trimax Bio sciences has successfully raised a total of $590.9K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $575.64 thousand completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $590,897
- Total Rounds 2
- Last Round Angel Round — $575,636
- First Round $15,261
(Mar 2017)
- Investors Count 10
All 2 funding rounds of Trimax Bio sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | $575,636 | Angel Round | $9.23M | Srinivasulu Devabattini | |
| Mar 2017 | $15,261 | Angel Round | $7.89M | A Shiva Lakshmi | – |
| Date | Valuation | Stage |
|---|---|---|
| Jan 2019 | $9.23M | •••••••• |
| Mar 2017 | $7.89M | •••••••• |
Last known valuation $9.23M (Jan 2019). 11 investors in total: 1 institutional and 10 angel.
Investors in Trimax Bio sciences
Trimax Bio sciences has secured backing from 11 investors, including angel investors. Prominent investors backing the company include Sigachi, Srinivasulu Devabattini and Nimmagadda Venkateswarlu.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SD Srinivasulu Devabattini | unknown_3d16b2a6f1204b5e9 | |||
NV Nimmagadda Venkateswarlu | unknown_5da98a8a86944f538 | |||
NP Nimmagadda Padmavathi | unknown_d8053c18dbca401c9 | |||
HL Hema Latha Devabathini | unknown_87ff8ec8ba5c40baa | |||
YD Yeswanth Devabathini | unknown_111674ec5d3c47e69 | |||
MS Manam Siva Kumari | unknown_76b24e07d13244499 | |||
KL Koduri Lakshmi Kantamma | unknown_fb1aa00735cd4fc78 | |||
VR Visweswara Rao | unknown_096c8f21f47243219 | |||
MS Manam Srinivasa Rao | unknown_e163e36c3a9d4cf79 | |||
AS A Shiva Lakshmi | unknown_4b4ee17495ab442d8 |
Investor details for Trimax Bio sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Trimax Bio Sciences Private Limited (Trimax Bio sciences)
Trimax Bio Sciences Private Limited is the primary company behind Trimax Bio sciences. The board of Trimax Bio Sciences Private Limited currently have 6 directors; the longest-serving is Chebrolu Murali Krishna, appointed in 2010. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chebrolu Murali Krishna DIN 01255657 | Director | 11 May 2010 | 16 yrs 6 mo | Trimax Bio Sciences Private Limited |
| Nageswara Rao Karusala DIN 03054340 | Director | 11 May 2010 | 16 yrs 6 mo | Trimax Bio Sciences Private Limited |
| Swati Sinha DIN 08097594 | Director | 09 Jan 2024 | 2 yrs 10 mo | Trimax Bio Sciences Private Limited |
| Dhanalakshmi Guntaka DIN 09363100 | Director | 09 Jan 2024 | 2 yrs 10 mo | Trimax Bio Sciences Private Limited |
| Amit Raj Sinha DIN 01263292 | Additional Director | 09 Jan 2024 | 2 yrs 10 mo | Trimax Bio Sciences Private Limited |
| Janardhana Reddy Yeddula DIN 03207357 | Director | 07 Mar 2025 | 1 yr 8 mo | Trimax Bio Sciences Private Limited |
People of Trimax Bio sciences
2 people are tracked at Trimax Bio sciences (2 in leadership); the tracked headcount is 113.
| Name | Role | Group |
|---|---|---|
K Jagadeeswari | Co-Founder & Managing Director | Leadership |
| Co-Founder | Leadership |
Complete people profiles for Trimax Bio sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Trimax Bio sciences
Figures of Trimax Bio Sciences Private Limited, the primary company behind Trimax Bio sciences, for FY 2025. Revenue was ₹29.26 Cr (-49% year on year). Net profit was ₹4.49 Cr (15% margin). EBITDA was ₹5.75 Cr (20% margin). Revenue has grown at a compounded annual rate of -18% over three years and -16% over five years.
- ₹29.26 CrRevenue · FY 2025 · -49% YoY
- ₹4.49 CrNet profit · 15% margin
- ₹5.75 CrEBITDA · 20% margin
- ₹36.00 CrPaid-up capital
- 113Employees (provident fund records)
- -18%Revenue CAGR, 3 years
- -16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Trimax Bio Sciences Private Limited are on its company page.
Detailed financial statements for Trimax Bio sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Trimax Bio sciences
5 dated milestones of Trimax Bio sciences across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Trimax Bio sciences is founded.
- Funding First funding round of $15K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $576K.
- Exit Acquired by Sigachi.
Competitors of Trimax Bio sciences
Trimax Bio sciences has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs |
Detailed competitors of Trimax Bio sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Trimax Bio sciences (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Trimax Bio Sciences
Complete news archive for Trimax Bio sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trimax Bio sciences
Trimax Bio sciences was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Trimax Bio sciences is headquartered in Raichur, India. It is registered at Raichur, Karnataka, India.
Trimax Bio sciences is a funded company, having raised a total of $590.9K across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $15.26K, raised on Mar 2017.
Trimax Bio sciences has 113 employees.
The primary company behind Trimax Bio sciences, Trimax Bio Sciences Private Limited, reported revenue of ₹29.26 Cr for FY 2025, down 49% year on year.
Trimax Bio sciences was established in 2011 in Raichur, India, within the pharmaceutical sector. Research on non-infringing processes is conducted, alongside manufacturing of various healthcare intermediates. Products such as metformin, pregabalin, dimethylphenoxyacetic acid, and pantoprazole sodium sesquihydrate are produced to support broader pharmaceutical applications. Operations remain centered on these core activities in the Indian market.
Trimax Bio sciences's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Trimax Bio sciences has 11 investors. Key investors include Sigachi, Srinivasulu Devabattini, Nimmagadda Venkateswarlu, Nimmagadda Padmavathi, and Hema Latha Devabathini.
The valuation of Trimax Bio sciences is $9.23M as of Jan 2019.
Trimax Bio sciences operates through Trimax Bio Sciences Private Limited.
Yes. Trimax Bio sciences was acquired by Sigachi in August 2023.
The legal entities of Trimax Bio sciences currently have 7 directors, including Chebrolu Murali Krishna, Battu Vinay Kanth Raj, Swati Sinha and others.